Browse by Person

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Item Type | Date | No Grouping
2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1992 | 1990
Number of items: 90.

2011

Osman, R., Kan, P.L., Awad, G., Mortada, N., EL-Shamy, A-E. and Alpar, H.O. (2011) Enhanced properties of discrete pulmonary deoxyribonuclease I (DNaseI) loaded PLGA nanoparticles during encapsulation and activity determination. International Journal of Pharmaceutics, 408 (1-2). pp. 257-265. 10.1016/j.ijpharm.2011.02.013.

2010

Florindo, H., Pandit, S., Goncalves, I., Alpar, H.O. and Almeida, A.J. (2010) Surface modified polymeric nanoparticles for immunisation against equine strangles. International Journal of Pharmaceutics, 390 (1). pp. 25-31. 10.1016/j.ijpharm.2009.10.009 .

Wang, Y., Lam, J., Zhang, B., Tomlins, P.E., Li, X., Alpar, H.O., Wertheim, D.F., Jones, A.S. and Coombes, A.G.A. (2010) Biomechanical Characterization of a Micro/Macroporous Polycaprolactone Tissue Integrating Vascular Graft. Cardiovascular Engineering and Technology, 1 (3). pp. 202-215. doi:10.1007/s13239-010-0019-1.

2009

Uchida, M., Li, X., Mertens, P. and Alpar, H.O. (2009) Transfection by particle bombardment: delivery of plasmid DNA into mammalian cells using gene gun. Biochimica et Biophysica Acta, 1790 (8). pp. 754-764. 10.1016/j.bbagen.2009.05.013.

Dahlan, A., Alpar, H.O. and Murdan, S. (2009) An investigation into the combination of low frequency ultrasound and liposomes on skin permeability. International Journal of Pharmaceutics, 379 (1). pp. 139-142. doi:10.1016/j.ijpharm.2009.06.011.

Wang, Y., Chang, H-I., Li, X., Alpar, H.O. and Coombes, A. (2009) Delivery of bioactive macromolecules from microporous polymer matrices: release and activity profiles of lysozyme, collagenase and catalase. European Journal of Pharmaceutical Sciences, 37 . pp. 387-394. 10.1016/j.ejps.2009.03.010.

Kaye, R.S., Purewal, T.S. and Alpar, H.O. (2009) Development and testing of particulate formulations for the nasal delivery of antibodies. Journal of Controlled Release, 135 (2). pp. 127-135. doi:10.1016/j.jconrel.2008.11.009.

Tse, M.T., Blatchford, C. and Alpar, H.O. (2009) Evaluation of different buffers on plasmid DNA encapsulation into PLGA microparticles. International Journal of Pharmaceutics, 370 (1-2). pp. 33-40. doi:10.1016/j.ijpharm.2008.11.006.

Florindo, H., Pandit, S., Goncalves, L., Alpar, H.O. and Almeida, A.J. (2009) New approach on the development of a mucosal vaccine against strangles: Systemic and mucosal immune responses in a mouse model. Vaccine, 27 (8). pp. 1230-1241. 10.1016/j.vaccine.2008.12.004.

Katas, H., Cevher, E. and Alpar, H.O. (2009) Preparation of polyethyleneimine incorporated poly(d,l-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery. International Journal of Pharmaceutics, 369 (1-2). pp. 144-154. doi:10.1016/j.ijpharm.2008.10.012.

Kaye, R.S., Purewal, T.S. and Alpar, H.O. (2009) Simultaneously manufactured nano-in-micro (SIMANIM) particles for dry-powder modified-release delivery of antibodies. Journal of Pharmaceutical Sciences, 98 (11). pp. 4055-4068. doi:10.1002/jps.21673.

Kaye, R.S., Purewal, T.S. and Alpar, H.O. (2009) Simultaneously manufactured nano-in-micro (SIMANIM) particles for dry-powder modified-release delivery of antibodies. Journal of Pharmaceutical Sciences, 98 (11). pp. 4055-4068. 10.1002/jps.21673.

Florindo, H.F., Pandit, S., Lacerda, L., Gonçalves, L.M.D., Alpar, H.O. and Almeida, A.J. (2009) The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-ɛ-caprolactone-based nanoparticles. Biomaterials, 30 (5). pp. 879-891. 10.1016/j.biomaterials.2008.10.035.

Sayin, B., Somavarapu, S., Li, X.W., Sesardic, D., Senel, S. and Alpar, H.O. (2009) TMC-MCC (N-trimethyl chitosan-mono-N-carboxymethyl chitosan) nanocomplexes for mucosal delivery of vaccines. European Journal of Pharmaceutical Sciences, 38 (4). pp. 362-369. 10.1016/j.ejps.2009.08.010.

Dahlan, A., Alpar, H.O., Stickings, P., Sesardic, D. and Murdan, S. (2009) Transcutaneous immunisation assisted by low-frequency ultrasound. International Journal of Pharmaceutics, 368 (1-2). pp. 123-128. doi:10.1016/j.ijpharm.2008.10.014.

2008

Katas, H., Chen, S., Osamuyimen, A.A., Cevher, E. and Alpar, H.O. (2008) Effect of preparative variables on small interfering RNA loaded Poly(D,L-lactide-co-glycolide)-chitosan submicron particles prepared by emulsification diffusion method. Journal of Microencapsulation, 25 (8). pp. 541-548. doi:10.1080/02652040802075567.

Sayın, B., Somavarapu, S., Li, X.W., Thanou, M., Sesardic, D., Alpar, H.O. and Şenel, S. (2008) Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery. International Journal of Pharmaceutics, 363 (1-2). pp. 139-148. 10.1016/j.ijpharm.2008.06.029.

Colonna, C., Conti, B., Genta, I. and Alpar, H.O. (2008) Non-viral dried powders for respiratory gene delivery prepared by cationic and chitosan loaded liposomes. International Journal of Pharmaceutics, 364 (1). pp. 108-118. 10.1016/j.ijpharm.2008.07.034.

Florindo, H., Pandit, S., Goncalves, L., Alpar, H.O. and Almeida, A.J. (2008) Streptococcus equi antigens adsorbed onto surface modified poly-ɛ-caprolactone microspheres induce humoral and cellular specific immune responses. Vaccine, 26 (33). pp. 4168-4177. 10.1016/j.vaccine.2008.05.074.

2007

Shaw, A., Monaghan, P., Alpar, H.O., Anthony, S., Darpel, K., Batten, C., Guercio, A., Alimena, G., Vitale, M. and Bankowska, K. (2007) Development and initial evaluation of a real-time RT-PCR assay to detect bluetongue virus genome segment 1☆. Journal of Virological Methods, 145 (2). pp. 115-126. 10.1016/j.jviromet.2007.05.014.

Pandit, S., Cevher, E., Zariwala, M.G., Somavarapu, S. and Alpar, H.O. (2007) Enhancement of immune response of HBsAg loaded poly (L-lactic acid) microspheres against Hepatitis B through incorporation of alum and chitosan. Journal of Microencapsulation, 24 (6). pp. 539-552. doi:10.1080/02652040701443700.

2006

Katas, H. and Alpar, H.O. (2006) Development and characterisation of chitosan nanoparticles for siRNA delivery. Journal of Controlled Release, 115 (2). pp. 216-225. 10.1016/j.jconrel.2006.07.021.

Dahlan, A., Alpar, H.O. and Murdan, S. (2006) A study into the application of ultrasound and liposome combination on skin permeability. In: British Pharmaceutical Conference, 2006.

Dahlan, A., Alpar, H.O. and Murdan, S. (2006) A study into the application of ultrasound and liposome combination on skin permeability. Journal of Pharmacy and Pharmacology, 58 . A46-A46.

Singh, J., Pandit, S., Bramwell, V.W. and Alpar, H.O. (2006) Diptheria toxoid loaded poly-(epsilon-caprolactone) nanoparticles as mucosal vaccine delivery systems. Methods, 38 (2). pp. 96-105. 10.1016/j.ymeth.2005.11.003 .

Dahlan, A., Alpar, H.O. and Murdan, S. (2006) Effect of SDS concentration in the coupling medium on ultrasound-induced changes in skin barrier. In: British Pharmaceutical Conference, 2006.

Dahlan, A., Alpar, H.O. and Murdan, S. (2006) Effect of SDS concentration in the coupling medium on ultrasound-induced changes in skin barrier. Journal of Pharmacy and Pharmacology, 58 (Suppl. 1). A45-A46.

Moschos, S.A., Bramwell, V.W., Somavarapu, S. and Alpar, H.O. (2006) Modulating the adjuvanticity of alum by co-administration of muramyl di-peptide (MDP) or Quil-A. Vaccine, 24 (8). pp. 1081-1086. 10.1016/j.vaccine.2005.09.007.

Dahlan, A., Alpar, H.O. and Murdan, S. (2006) Needle-free skin immunization using low frequency ultrasound. Journal of Pharmacy and Pharmacology, 58 . A45-A45.

Dahlan, A., Alpar, H.O. and Murdan, S. (2006) Needle-free skin immunization using low-frequency ultrasound. In: British Pharmaceutical Conference, 2006.

Elvin, S.J., Eyles, J.E., Howard, K.A., Ravichandran, E., Somavarapu, S., Alpar, H.O. and Williamson, E.D. (2006) Protection against bubonic and pneumonic plague with a single dose microencapsulated sub-unit vaccine. Vaccine, 24 . pp. 4433-4439. 10.1016/j.vaccine.2005.12.016.

Dahlan, A., Alpar, H.O. and Murdan, S. (2006) Skin immunization using ultrasound: potential of low sodium dodecyl sulphate concentration for producing synergistic effects. In: AAPS Annual Meeting, 29th October - 2nd November 2006, San Antonio, Texas, USA.

Bridson, R.H., Santos, R.C.D., Al-Duri, B., McAllister, S.M., Robertson, J. and Alpar, H.O. (2006) The preparation of liposomes using compressed carbon dioxide: strategies, important considerations and comparison with conventional techniques. Journal of Pharmacy and Pharmacology, 58 (6). pp. 775-785. 10.1211/jpp.58.6.0008.

2005

Dahlan, A., Alpar, H.O. and Murdan, S. (2005) Abstract: An investigation into protein stability following low-frequency ultrasound application. In: British Pharmaceutical Conference, 2005. DOI 10.1211/002235705778248352.

Dahlan, A., Alpar, H.O. and Murdan, S. (2005) Abstract: An investigation into protein stability following low-frequency ultrasound application. Journal of Pharmacy and Pharmacology, 57 . 10.1211/002235705778248352.

Dahlan, A., Alpar, H.O. and Murdan, S. (2005) Abstract: Effect of coupling medium volume on sonophoresis of proteins. In: British Pharmaceutical Conference, 2005. DOI 10.1211/002235705778248479.

Dahlan, A., Alpar, H.O. and Murdan, S. (2005) Abstract: Effect of coupling medium volume on sonophoresis of proteins through rat skin. Journal of Pharmacy and Pharmacology, 57 . S51-S51.

Dahlan, A., Alpar, H.O. and Murdan, S. (2005) Abstract: Effect of probe distance on sonophoresis of proteins through rat skin. Journal of Pharmacy and Pharmacology, 57 . S51-S51.

Dahlan, A., Alpar, H.O. and Murdan, S. (2005) Abstract: Effect of surfactant concentration on sonophoresis of proteins through rat skin. In: British Pharmaceutical Conference, 2005. DOI 10.1211/002235705778248479.

Dahlan, A., Alpar, H.O. and Murdan, S. (2005) Abstract: Effect of surfactant concentration on sonophoresis of proteins through rat skin. Journal of Pharmacy and Pharmacology, 57 (Supp S). S51-S52.

Alpar, H.O., Somavarapu, S., Atuah, K.N. and Bramwell, V.W. (2005) Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery. Advanced Drug Delivery Reviews, 57 (3). pp. 411-430. 10.1016/j.addr.2004.09.004.

Pollitt, M.J., Buckton, G., Brocchini, S. and Alpar, H.O. (2005) Calorimetric study of bovine serum albumin dilution and adsorption onto polystyrene particles. International Journal of Pharmaceutics, 298 (2). pp. 339-343. 10.1016/j.ijpharm.2005.02.037.

Martin, C., Thongborisute, J., Takeuchi, H., Yamamoto, H., Kawashima, Y. and Alpar, H.O. (2005) Cholesterol-bile salt vesicles as potential delivery vehicles for drug and vaccine delivery. International Journal of Pharmaceutics, 298 (2). pp. 339-343. 10.1016/j.ijpharm.2005.03.038 .

Moschos, S.A., Bramwell, V.W., Somavarapu, S. and Alpar, H.O. (2005) Comparative immunomodulatory properties of a chitosan-MDP adjuvant combination following intranasal or intramuscular immunisation. Vaccine, 23 (16). pp. 1923-1930. 10.1016/j.vaccine.2004.10.016 .

Dahlan, A., Alpar, H.O. and Murdan, S. (2005) Effect of probe distance on sonophoresis of proteins through rat skin. In: British Pharmaceutical Conference, 2005.

Somavarapu, S., Pandit, S., Gradassi, G., Bandera, M., Ravichandran, E. and Alpar, H.O. (2005) Effect of Vitamin E TPGS on immune response to nasally delivered diphtheria toxoid load poly(caprolactone) microparticles. International Journal of Pharmaceutics, 298 (2). pp. 344-347. 10.1016/j.ijpharm.2005.03.029 .

Murdan, S., Somavarapu, S., Ross, A.C., Alpar, H.O. and Parker, M.C. (2005) Immobilisation of vaccines onto micro-crystals for enhanced thermal stability. International Journal of Pharmaceutics, 296 (1-2). pp. 117-121. 10.1016/j.ijpharm.2005.02.022 .

Papanicolaou, I., Briggs, B. and Alpar, H.O. (2005) Increased resistance of DNA lipoplexes to protein binding in vitro by surface-modification with a multivalent hydrophilic polymer. Journal of Drug Targeting, 12 (8). pp. 541-547. 10.1080/10611860400011950.

Hansen, R.K., Zhai, S., Skepper, J.N., Johnston, M.D., Alpar, H.O. and Slater, N.K.H. (2005) Mechanisms of inactivation of HSV-2 during storage in frozen and lyophilised forms. Biotechnology Progress, 21 (3). pp. 911-917. 10.1021/bp049601a.

Martin, C., Somavarapu, S. and Alpar, H.O. (2005) Mucosal delivery of diptheria toxoid using polymer-coated-bioadhesive liposomes as vaccine carriers. Journal of Drug Delivery Science and Technology, 15 (4). pp. 301-306.

Alpar, H.O. and Brey, R.N. (2005) New frontiers in vaccines for emerging pathogens. Advanced Drug Delivery Reviews, 57 (9). pp. 1243-1246. 10.1016/j.addr.2005.01.029.

Dahlan, A., Alpar, H.O. and Murdan, S. (2005) Optimisation of low-frequency ultrasound parameters for transcutaneous protein delivery. Journal of Pharmacy and Pharmacology, 57 . S50-S51.

Bramwell, V.W., Eyles, J.E. and Alpar, H.O. (2005) Particulate delivery systems for biodefense subunit vaccines. Advanced Drug Delivery Reviews, 57 (3). pp. 1247-1265. 10.1016/j.addr.2004.09.009.

Pandit, S., Martin, C. and Alpar, H.O. (2005) Positively charged rifampicin-loaded microspheres for lung delivery. Journal of Drug Delivery Science and Technology, 15 (4). pp. 281-287.

Alpar, H.O., Papanicolaou, I. and Bramwell, V.W. (2005) Strategies for DNA vaccine delivery. Expert Opinion on Drug Delivery, 2 (5). pp. 829-842. 10.1517/17425247.2.5.829.

2004

Moschos, S.A., Bramwell, V.W., Somavarapu, S. and Alpar, H.O. (2004) Adjuvant synergy: the effects of nasal coadministration of adjuvants. Immunology and Cell Biology, 82 (6). pp. 628-637. 10.1111/j.0818-9641.2004.01280.x.

Kusonwiriyawong, C., Atuah, K.N., Alpar, H.O., Merkle, H.P. and Walter, E. (2004) Cationic stearylamine-containing biodegradable microparticles for DNA delivery. Journal of Microencapsulation, 21 (1). pp. 25-36. 10.1080/02652040410001653777.

Howard, K.A., Li, X., Somavarapu, S., Singh, J., Green, N., Atuah, K.N., Ozsoy, Y., Seymour, L.W. and Alpar, H.O. (2004) Formulation of microparticle carrier for oral polyplex-based DNA vaccines. Biochimica et Biophysica Acta, 1674 (2). pp. 149-157. 10.1016/j.bbagen.2004.06.009.

Eyles, J.E., Elvin, S.J., Westwood, A., Lebutt, C.S. and Alpar, H.O. (2004) Immunisation against plague by transcutaneous and intradermal application of subunit antigens. Vaccine, 22 (31-32). 4365 -4373. 10.1016/j.vaccine.2004.02.049.

Eyles, J.E., Elvin, S.J., Westwood, A., Lebutt, C.S., Alpar, H.O., Somavarapu, S. and Williamson, E.D. (2004) Immunisation against plague by transcutaneous and intradermal application of subunit antigens. Vaccine, 22 (31-32). p. 4365. 10.1016/j.vaccine.2004.02.049.

Kohli, A.K. and Alpar, H.O. (2004) Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge. International Journal of Pharmaceutics, 275 (1-2). pp. 13-17. 10.1016/j.ijpharm.2003.10.038 .

2003

Eyles, J.E., Bramwell, V.W., Singh, J., Williamson, E.D. and Alpar, H.O. (2003) Stimulation of spleen cells in vitro by nanospheric particles containing antigen. Journal of Controlled Release, 86 (1). pp. 25-32. 10.1016/S0168-3659(02)00296-1 .

Bramwell, V.W., Somavarapu, S., Outschoorn, I. and Alpar, H.O. (2003) Adjuvant action of melittin following intranasal immunisation with tetanus and diphtheria toxoids. Journal of Drug Targeting, 11 (8-10). pp. 525-530. 10.1080/10611860410001683013.

Atuah, K.N., Walter, E., Merkle, H.P. and Alpar, H.O. (2003) Encapsulation of plasmid DNA in PLGA-stearylamine microspheres: a comparison of solvent evaporation and spray-drying methods. Journal of Microencapsulation, 20 (3). pp. 387-399. 10.1080/10611860410001683013.

Eyles, J.E., Carpenter, Z.C., Alpar, H.O. and Williamson, E.D. (2003) Immunological aspects fo polymer microsphere vaccine delivery systems. Journal of Drug Targeting, 11 . pp. 509-514. 10.1080/10611860410001670017.

Somavarapu, S., Bramwell, V.W. and Alpar, H.O. (2003) Oral plasmid DNA delivery systems for genetic immunisation. Journal of Drug Targeting, 11 (8-10). pp. 547-553. 10.1080/10611860410001683022.

Alpar, H.O., Murdan, S., Outschoorn, I., Bramwell, V.W. and Somavarapu, S. (2003) Quil-A - Chitosan: A novel mucosal adjuvant. In: MVADS Conference, 4-6 June 2003, Dublin, Republic of Ireland.

Alpar, H.O. (2003) Strategies for vaccine delivery. Journal of Drug Targeting, 11 (8-10). pp. 459-461. 10.1080/10611860410001683013.

Li, X., Lee, D.K., Chan, A.S. and Alpar, H.O. (2003) Sustained expression in mammalian cells with DNA complexed with chitosan nanoparticles. Biochimica et Biophysica Acta, 1630 (1). pp. 387-399.

Murdan, S., Ross, A.C., Parker, M.C., Alpar, H.O. and Somavarapu, S. (2003) Vaccine-coated microcrystals: Enhanced thermal stability of diphtheria taxoid. Journal of Pharmacy and Pharmacology, 55 (Supplement). S.71-S.72.

Murdan, S., Ross, A.C., Parker, M.C., Alpar, H.O. and Somavarapu, S. (2003) Vaccine-coated microcrystals: enhanced thermal stability of diphtheria toxoid. In: British Pharmaceutical Conference, 2003.

2002

Bramwell, V.W., Eyles, J.E., Somavarapu, S. and Alpar, H.O. (2002) Liposome/DNA complexes coated with biodegradable PLA improve immune responses to plasmid encoding hepatitis B surface antigen. Immunology, 106 (3). pp. 412-418. 10.1046/j.1365-2567.2002.01448.x.

Flick-Smith, H.C., Eyles, J.E., Hebdon, R., Waters, E.L., Beedham, R.J., Stagg, T.J., Miller, J., Alpar, H.O., Baillie, L.W.J. and Williamson, E.D. (2002) Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice. Infection and Immunity, 70 (4). pp. 2022-2028. 10.1128/IAI.70.4.2022-2028.2002.

Alpar, H.O. and Bramwell, V.W. (2002) Current status of DNA vaccines and their route of administration. Critical Reviews in Therapeutic Drug Carrier Systems, 19 (4-5). pp. 307-383. 10.1615/CritRevTherDrugCarrierSyst.v19.i45.

Griffin, K.F., Eyles, J.E., Spiers, I.D., Alpar, H.O. and Williamson, E.D. (2002) Protection against plague following immunisation with microencapsulated V antigen is reduced by co-encapsulation with IFN-gamma or IL-4, but not IL-6. Vaccine, 20 (31-32). pp. 3650-3657. 10.1016/S0264-410X(02)00396-1.

Howard, K.A. and Alpar, H.O. (2002) The development of polyplex-based DNA vaccines. Journal of Drug Targeting, 10 (2). pp. 143-151.

2001

Alpar, H.O., Eyles, J.E., Williamson, E.D. and Somavarapu, S. (2001) Intranasal vaccination against plague, tetanus and diphtheria. Advanced Drug Delivery Reviews, 51 (1-3). pp. 173-201. 10.1016/S0169-409X(01)00166-1 .

Eyles, J.E., Bramwell, V.W., Williamson, E.D. and Alpar, H.O. (2001) Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration. Vaccine, 19 (32). pp. 4732-4742. 10.1016/S0264-410X(01)00220-1.

Eyles, J.E., Spiers, I.D., Williamson, E.D. and Alpar, H.O. (2001) Tissue distribution of radioactivity following intranasal administration of radioactive microspheres. Journal of Pharmacy and Pharmacology, 53 (5). pp. 601-607. 10.1211/0022357011775929.

2000

Eyles, J.E., Williamson, E.D., Spiers, I.D., Stagg, A.J., Jones, S.M. and Alpar, H.O. (2000) Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant subunits. Journal of Controlled Release, 63 (1-2). pp. 191-200. 10.1016/S0168-3659(99)00197-2.

1999

Ward, K, Adams, G.D.J, Alpar, H.O. and Irwin, W. (1999) Protection of the enzyme ?-asparaginase during lyophilisation—a molecular modelling approach to predict required level of lyoprotectant. International Journal of Pharmaceutics, 187 (2). pp. 153-162. 10.1016/S0378-5173(99)00163-5.

1998

Griffin, K.F., Conway, B.R., Alpar, H.O. and Williamson, E.D. (1998) Immune responses to V antigen of Yersinia pestis co-encapsulated with IFN-$gamma;: effect of dose and formulation. Vaccine, 16 (5). pp. 517-521.

1997

Conway, B., Eyles , J.E. and Alpar, H.O. (1997) A comparative study on the immune responses to antigens in PLA and PHB microspheres. Journal of Controlled Release, 49 (1). pp. 1-9. 10.1016/S0168-3659(97)01641-6.

1996

McAllister, S.M., Alpar, H.O., Teitelbaum, Z. and Bennett, D.B. (1996) Do interactions with phospholipids contribute to the prolonged retention of polypeptides within the lung? Advanced Drug Delivery Reviews, 19 (1). pp. 89-110. 10.1016/0169-409X(95)00101-C.

Ward, K., Alpar, H.O., Adams, G., Atuah, K.N. and Irwin, W. (1996) Effects of lyophilisation on the formation and stability of stealth liposomes. European Journal of Pharmaceutical Sciences, 4 (Supp 1). S173. 10.1016/S0928-0987(97)86522-0.

1995

Poyner, E., Alpar, H.O., Almeida, A.J., Gamble, M.D. and Brown, M.R.W. (1995) A comparative study on the pulmonary delivery of tobramycin encapsulated into liposomes and PLA microspheres following intravenous and endotracheal delivery. Journal of Controlled Release, 35 (1). pp. 41-48. 10.1016/0168-3659(95)00017-3.

1994

Almeida, A.J. and Alpar, H.O. (1994) P281 microsphere adjuvanticity: Influence of polymer, dose and size on the humoral response to microencapsulated tetanus toxoid. European Journal of Pharmaceutical Sciences, 2 (1-2). p. 189.

1992

Alpar, H.O., Bowen, J. and Brown, M.R.W. (1992) Effectiveness of liposomes as adjuvants of orally and nasally administered tetanus toxoid. International Journal of Pharmaceutics, 88 (1-3). pp. 335-344. 10.1016/0378-5173(92)90332-V.

Bowen, J., Alpar, H.O., Phillpotts, R. and Brown, M.R.W. (1992) Mucosal delivery of herpes simplex virus vaccine. Research in Virology, 143 . pp. 269-278. 10.1016/S0923-2516(06)80115-9.

1990

Alpar, H.O., Bason, A., Hickman, J., Richards, F. and Field, W. (1990) Estimation by FACS of the delivery of liposome encapsulated macromolecules into myeloid cells. International Journal of Pharmaceutics, 62 (2-3). pp. 133-141. 10.1016/0378-5173(90)90227-U.

This list was generated on Wed Apr 16 08:23:00 2014 BST.